Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

GLOBUS MEDICAL INC (GMED) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Quarterly results
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: ":"
06/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2021 EQUITY INCENTIVE PLAN, AS AMENDED"
05/17/2023 4 Lemaitre Dan (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Sold 43,450 shares @ $56.9845, valued at $2.5M
Exercised 1,450 options to buy @ $23.95, valued at $34.7k
Exercised 10,500 options to buy @ $24.1, valued at $253.1k
Exercised 14,000 options to buy @ $25.52, valued at $357.3k
Exercised 17,500 options to buy @ $26.27, valued at $459.7k
05/16/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
05/03/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/02/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/17/2023 8-K Quarterly results
04/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/03/2023 8-K Other Events  Interactive Data
03/29/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/24/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
03/16/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
02/27/2023 4 ZARRILLI STEPHEN T (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 TOBIN JAMES R (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 RHOADS ANN D (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 Lemaitre Dan (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 Douglas Robert Andrew (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 Davidar David D (Director) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 15,000 options to buy @ $75.18, valued at $1.1M
02/27/2023 4 Huller Kelly (SVP, GC, Corporate Secretary) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 30,000 options to buy @ $75.18, valued at $2.3M
02/27/2023 4 Pfeil Keith W (SVP, CFO) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 40,000 options to buy @ $75.18, valued at $3M
02/27/2023 4 Paul David C (Executive Chairman) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 75,000 options to buy @ $75.18, valued at $5.6M
02/27/2023 4 Scavilla Daniel T (President, CEO) has filed a Form 4 on GLOBUS MEDICAL INC
Txns: Granted 100,000 options to buy @ $75.18, valued at $7.5M
02/22/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/21/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reports a 8% stake in GLOBUS MEDICAL INC
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy